PSMA PET Scan and mpMRI for Prostate Cancer Detection
Status:
Not yet recruiting
Trial end date:
2026-05-01
Target enrollment:
Participant gender:
Summary
Prospective, randomized, phase 2 clinical trial to determine if PSMA PET imaging plus mpMRI
improves detection of clinically significant prostate cancer as compared to mpMRI alone.